CNCRLoncar Cancer Immunotherapy ETF(Exchange Traded Fund )
XTF Rating* 2.8
Price:$26.06 -0.43(-1.62%)
52 Week:$12 - $28
Volume: 9,217
Avg Daily Volume: 17,501
Market Cap: $42,384,000 Avg Trade Size: 183 shares
Fund Turnover: 106 days 6/4/2020 3:59:45 PM
Similar ETFs to CNCR: IDNA, IBB, GDNA, SBIO, IXJ

Loncar Cancer Immunotherapy ETF is an exchange-traded fund incorporated in the USA. The Loncar Cancer Immunotherapy ETF seeks to track the total return performance, before fees and expenses, of the Loncar Cancer Immunotherapy Index (the 'Index'). The Index is composed of the common stock of approximately 30 pharmaceutical or biotechnology companies identified by Loncar Investments, LLC ('Loncar' or the 'Index Provider'), the Fund’s index provider, as having a high strategic focus on the development of drugs that harness the body’s own immune system to fight cancer ('immunotherapy').

Inception Date: 10/13/2015Geography: Global  Asset Class: Equity
Primary Exchange: NASDAQ Stock MarketInvestment Philosophy: Passively ManagedCapitalization: Broad/Multi Cap
Issuer: Exchange Traded ConceptsUnderlying Index: Loncar Cancer Immunotherapy IndexSector: Healthcare > Healthcare Multi-Industry
Index Provider: Loncar Investments, LLCIndex Composition: Equal-Weighted

Structural Integrity
Investment Metrics
Fund Holdings
Fund Exposure
News Headlines
CNCR Structural Integrity ranks in the 20th percentile (among all 1552 Equity ETFs over past 6 months).
as of 3/31/2020 Value  Rank (%)
Expense Ratio 0.79% 
 18.8%
Average Bid Ask Ratio Premium Content 
 23.4%
Tracking Error Premium Content 
 63.1%
Concentration Risk Premium Content 
 42.3%
Market Impact Premium Content 
 37.3%
Efficiency Premium Content 
 43.8%
Cap Gains Dist Premium Content 
 100%
     
as of 6/3/2020  
Avg Number of Components   (range) 25   (1-26)
Legal Structure Open-End Investment Company 
Annual Yield / SEC Yield 0.00% / -0.3%
Last Dividend PaidDate 0.0, n/a   See Distributions
Options / Futures Available N  /  N 
Short Interest / Days to Cover N.A. /  N.A.
Net Asset Value $42,358,560 
Premium (Discount) 0.06% 
*The XTF Rating for an ETF is based on statistical analysis of its structural integrity and investment metric giving a total range between 0 and 10 with 10 being the best. Read More.





© LSEG Information Services (US) Inc., All Rights Reserved. Disclaimer. Terms of Use. Privacy Policy. Cookie Policy. .10